Olga Danov

Statistics

Publications

Citations

1.1K

H-Index

Active since

2016

Affiliations

Fraunhofer Institute for Toxicology and Experimental Medicine(Current)

German Center for Lung Research

Medizinische Hochschule Hannover

German Primate Center

Klinikum Region Hannover

Olga Danov is an author at Fraunhofer Institute for Toxicology and Experimental Medicine specializing in immunology, life sciences, and infectious diseases.

ORCID

Publications per year

2016–2023

Publications

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

Markus Hoffmann, Heike Hofmann-Winkler, Joan C. Smith et al. · EBioMedicine · 2021 · 398 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +16

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Melissa Zimniak, Luisa Kirschner, Helen Hilpert et al. · Scientific Reports · 2021 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Biological effects of carbon black nanoparticles are changed by surface coating with polycyclic aromatic hydrocarbons

Karina Lindner, Michael Ströbele, Sandra Schlick et al. · Particle and Fibre Toxicology · 2017 · 85 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +17

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Vanessa Neuhaus, Olga Danov, Sebastian Konzok et al. · Journal of Visualized Experiments · 2018 · 60 citations · Full text

Pharmacy, Immunology, Toxicology +17

TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1

Paweł Zmora, Markus Hoffmann, Heike Kollmus et al. · Journal of Biological Chemistry · 2018 · 60 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

1–5 of 16